Drug Delivery & Microbiology Research Discipline

Understanding the nature of biological barriers and developing advanced systems to improve the delivery of therapeutics
Understanding microbial survival strategies, microbial contamination of pharmaceutical products, control of microbial infection in healthcare environments
(Joint coordinators, James Birchall & Les Baillie )
Expertise includes: molecular imprinting; pharmaceutical engineering of therapeutic microneedles; technological & biological aspects of transcutaneous drug and gene delivery; technological & biological aspects of pulmonary drug and gene delivery; synthesis and exploitation of novel polymer systems; technological & biological aspects in the tissue and cellular trafficking of macromolecules; phage as a therapeutic and a display technology; bioimaging; quantitative analytical chemistry; particle characterisation; technological and biological aspects of the study of biocides, formulation preservation and biofilm formation; vaccine development.
Specialist facilities include: imaging and cytometry facilities, containment laboratories and suites for prokaryote and eukaryote investigations, cell and molecular biology resources, a dedicated ultra centrifuge suite, advanced chromatographic equipment, polymer chemistry equipment for synthesis and characterisation, and a GMP suite for clinical trial formulation .
Current research interests include:
- pulmonary drug delivery
- microneedle delivery of drugs and biologics
- stability of total parenteral nutrition admixtures
- molecular imprinting
- cell membrane penetration
- transdermal penetration of drugs
- interaction of microorganisms with pharmaceuticals
- antimicrobial mechanisms
- diagnostics for infectious agents, especially B.anthracis and Cl. difficile
Latest News
12/01/2011
to attend the 3rd International Clostridium difficile Symposium in Bled, Slovenia, 22- 24th September 2010
SGM's Microbiology Communication Prize is given to Callum Cooper, WSP Alumni (PhD 2007-2011).
Dr Arwyn Jones visited South Africa as part of a collaborative Bill & Melinda Gates Foundation research award to study new methods for targeting the Tuberculosis bacterium in macrophages.
Wales-Ireland industry-academia partnership in smart drug delivery fits government vision and promises improved therapies.
09/09/2010
The University confers the title Professor of Drug Delivery on Dr Glyn Taylor
